Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Holista Colltech Limited ( (AU:HCT) ) just unveiled an update.
Holista Colltech Limited has requested and been granted a voluntary suspension of trading in its ordinary shares on the ASX under Listing Rule 17.2, pending the release of an announcement regarding a legal matter involving ProImmune Company LLC. The suspension will remain in place until normal trading resumes on 14 April 2026 or until the company issues the anticipated announcement and asks for the suspension to be lifted, signalling potential legal or operational developments of interest to shareholders and the market.
The most recent analyst rating on (AU:HCT) stock is a Sell with a A$0.06 price target. To see the full list of analyst forecasts on Holista Colltech Limited stock, see the AU:HCT Stock Forecast page.
More about Holista Colltech Limited
Holista Colltech Limited is an ASX-listed company operating in the health and wellness sector, though this announcement does not specify its core products or services. The company is listed under the ticker HCT on the Australian Securities Exchange and is subject to ASX listing rules and compliance requirements as a publicly traded entity.
Average Trading Volume: 39,434
Technical Sentiment Signal: Hold
Current Market Cap: A$23.17M
Learn more about HCT stock on TipRanks’ Stock Analysis page.